As age is the strongest risk factor in NMSC, dermatologists can see an increase in this type of cancer in elderly patients, and treatment preferences vary.
Cheryl Guttman Krader
Newer and emerging modalities are addressing the need for better therapeutic options for vitiligo, but there remains a broader need for dermatologists to understand the existing, useful therapies for this disfiguring, but undertreated autoimmune condition.
Psoriasis does not appear to impact fertility, but there are conflicting data on whether psoriasis itself affects the risk of pregnancy complications in women of childbearing age. This expert weighs in on the subject.
About one-third of patients with psoriasis are children or adolescents. Still, little research exists on treating this patient population. New disease management guidelines and emerging studies seek to fill the gap.
Pulsed dye laser (PDL) is widely accepted as the gold standard treatment of port-wine stains (PWS), but how early can you begin treating infants with PWS? According to this expert and a recent study, the sooner the better.
Learn about Nano-Pulse Stimulation and how this novel technology could potentially treat both benign and malignant dermatologic lesions.
A retrospective review of pediatric patients treated for psoriasis with systemic agents provides much needed insight about the safety and tolerability of these medications.
Two novel energy-based approaches are ushering in a new era in acne treatment. One expert addresses the role these devices may play.
New findings support dietary and supplementation practices that can influence acne. One expert discusses modifications in context of protocols for managing the condition.
Guidelines for the diagnosis and treatment of pediatric acne developed by the American Acne Rosacea Society (AARS) and endorsed by the American Academy of Pediatrics (AAP) provide the AAP with its first-ever evidence-based guidelines for the management of this very common pediatric condition.